G M Frasca
Overview
Explore the profile of G M Frasca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DArezzo M, Balestra E, Fanciulli E, Freddi P, Sagripanti S, Mazzucchelli R, et al.
G Ital Nefrol
. 2009 Oct;
26(5):621-4.
PMID: 19802808
This study reports on a 67-year-old man, suffering from type 2 diabetes mellitus for 11 years along with arterial hypertension and autoimmune thyroiditis, in whom nephrotic proteinuria was detected together...
2.
Passerini P, Scolari F, Frasca G, Leoni A, Venturelli C, Dallera N, et al.
G Ital Nefrol
. 2009 Oct;
26(5):563-76.
PMID: 19802802
Primary focal segmental glomerular sclerosis (FSGS) commonly presents with nephrotic syndrome. Spontaneous remission is rare and persistent nephrotic syndrome is a marker of poor prognosis. For this reason, obtaining remission...
3.
Frasca G, Balestra E, Fanciulli E, Freddi P, Mazzucchelli R, Montironi R, et al.
G Ital Nefrol
. 2008 Feb;
25(1):49-56.
PMID: 18264918
Thin glomerular basement membrane disease (TBMD) is a hereditary nephropathy characterized by thinning of the glomerular basement membrane evinced by electron microscopy and, clinically, by isolated hematuria without extrarenal manifestations....
4.
Cautero N, De Luca S, Vecchi A, Garelli P, Nicolini D, Martorelli G, et al.
Transplant Proc
. 2007 Aug;
39(6):2038-9.
PMID: 17692686
Sarcomas are rare neoplasms, accounting for a 1.7% incidence among all transplanted patients presenting with de novo malignancies. Our present report focused on a 46-year-old woman who received immunosuppressive therapy...
5.
Frasca G, Stefoni S
G Ital Nefrol
. 2003 Oct;
20(4):400-13.
PMID: 14523902
Recent advances in immunosuppressive therapy have dramatically reduced the incidence of acute rejection, thus improving graft survival. As a result, the importance of recurrence of the original nephropathy as a...
6.
Frasca G, Canova C, Preda P, Pasquinelli G, Soverini M, VANGELISTA A, et al.
Contrib Nephrol
. 2001 Nov;
(136):211-5.
PMID: 11688382
No abstract available.
7.
Gharavi A, Yan Y, Scolari F, Schena F, Frasca G, Ghiggeri G, et al.
Nat Genet
. 2000 Nov;
26(3):354-7.
PMID: 11062479
End-stage renal disease (ESRD) is a major public health problem, affecting 1 in 1,000 individuals and with an annual death rate of 20% despite dialysis treatment. IgA nephropathy (IgAN) is...
8.
Frasca G, Renieri A
J Nephrol
. 2000 Mar;
13(1):15-9.
PMID: 10720210
The term thin glomerular basement membrane disease (TBMD) refers to a condition characterised by thinning of the GBM at electron microscopy examination and, clinically, by isolated hematuria, frequently occurring in...
9.
VANGELISTA A, Stipo L, Canova C, Frasca G, Iannelli S, Nanni-Costa A, et al.
Ren Fail
. 1996 Sep;
18(5):755-63.
PMID: 8903090
No abstract available.
10.
Frasca G, Martello M, Sestigiani E, Canova C, VANGELISTA A, Bonomini V
Nephrol Dial Transplant
. 1996 Feb;
11(2):392-3.
PMID: 8700366
No abstract available.